Concord News Now

Veterinary Vaccines Market: Opportunities and Challenges

 Breaking News
  • No posts were found

Veterinary Vaccines Market: Opportunities and Challenges

November 02
22:24 2019
Veterinary Vaccines Market: Opportunities and Challenges

The key players in the Veterinary Vaccines Market include Zoetis (US), Merck Animal Health (US), Elanco Animal Health (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France).
The introduction of new vaccines is expected to offer lucrative growth opportunities to animal vaccine manufacturers.

The global veterinary vaccines market is expected to reach USD 8,655.2 million by 2022 from USD 6,500.7 million in 2017, at a CAGR of 5.9% from 2017 to 2022. Factors such as growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines are driving growth of the veterinary vaccines market. On the other hand, the high storage cost for vaccines is restraining market growth.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233

How are technological advancements providing opportunities in Animal Vaccines market?

The veterinary vaccines technology has evolved significantly over the past decade. This is mainly due to the constant emergence of new diseases or the re-emergence of mutated diseases. Conventional live and inactivated vaccines are sometimes exposed to risks of mutation and have a short shelf life. Similarly, the challenge of strain/region specificity makes conventional vaccines ineffective. To combat these limitations, technologically advanced recombinant and DNA vaccines are being introduced in the market.

The introduction of new vaccines is expected to offer lucrative growth opportunities to animal vaccine manufacturers. These vaccines induce a wider range of immune responses; are easy to produce, store, and transport; can be rapidly developed to combat emerging diseases; and are highly stable as opposed to other vaccine types. DNA vaccines are capable of inducing potent cellular and humoral immune responses and display higher stability at a wider range of temperatures, which also reduces the cost incurred in maintaining the recommended temperature. After successful preclinical tests for H1N1 influenza, players such as VGX Animal Health are now increasing their focus on developing DNA vaccines. The healthy growth in this market is indicative of the opportunities available in this market segment.

Moreover, technological advancements in other areas are enabling real-time communication using mobiles to send information to pet owners/livestock farmers for timely vaccination and medication. This, in turn, is increasing the adherence to vaccination programs among pet owners and livestock farmers.

How inadequate surveillance and reporting systems pose challenges in Animal Vaccines market?

In many cases, despite initiatives to promote the use of vaccines, the overall vaccine coverage is found to be low. This is mainly due to the lack of awareness about vaccination and inadequate surveillance and reporting systems. Even when vaccines are available, a lack of data can complicate decisions about areas where vaccines are needed. Moreover, surveillance and reporting systems are still inadequate for many diseases and in many countries, which is resulting in the late diagnosis and reporting of disease outbreaks. This issue is primarily related to funding, as farmers are often reluctant to pay for diagnostic tests or surveillance and reporting. Investments and funding for improving surveillance and reporting systems are expected to ultimately transfer the benefits to human health by reducing the overall prevalence of zoonotic diseases. However, until such investments are made available, the presence of inadequate surveillance and reporting systems is expected to continue to hinder the large-scale use of vaccines.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1233

Browse Related Reports:

Veterinary Imaging Market by Product (Ultrasound, Radiography, MRI, Video Endoscopy), Therapeutic Area (Oncology, Cardiology, Neurology, Orthopedic), Animal (Small Companion Animals, Large Animals), End User (Hospital, Clinic) – Global Forecast to 2022

Dairy Herd Management Market by Product (Automated Systems (Milking Parlours, Meters, Sensors, Reproductive & Health, Cattle Management), Software (On-premise, Cloud-based)), Application (Feeding, Breeding), End user (Large Farms) – Global Forecast to 2022

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html